Allspring Global Investments Holdings, LLC Entrada Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 27,631 shares of TRDA stock, worth $471,661. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,631
Previous 14,763
87.16%
Holding current value
$471,661
Previous $209,000
88.04%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TRDA
# of Institutions
85Shares Held
27.7MCall Options Held
100Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$83.1 Million0.92% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$75.5 Million34.63% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$75.3 Million29.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.13MShares$53.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$28.9 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $535M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...